These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15628831)

  • 1. Bone disorders associated with the human immunodeficiency virus: pathogenesis and management.
    Qaqish RB; Sims KA
    Pharmacotherapy; 2004 Oct; 24(10):1331-46. PubMed ID: 15628831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management.
    Bongiovanni M; Tincati C
    Curr Mol Med; 2006 Jun; 6(4):395-400. PubMed ID: 16900662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies.
    Walker Harris V; Brown TT
    J Infect Dis; 2012 Jun; 205 Suppl 3(Suppl 3):S391-8. PubMed ID: 22577213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
    Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Disease in HIV: Recommendations for Screening and Management in the Older Patient.
    Hoy J
    Drugs Aging; 2015 Jul; 32(7):549-58. PubMed ID: 26123948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
    Carr A; Miller J; Eisman JA; Cooper DA
    AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging bone problems in patients infected with human immunodeficiency virus.
    Mondy K; Tebas P
    Clin Infect Dis; 2003 Apr; 36(Suppl 2):S101-5. PubMed ID: 12652379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
    Guo FP; Yu XB; Luo L; Han Y; Qiu ZF; Zuo LY; Li YL; Yu W; Li TS
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis and multiple fractures in an antiretroviral-naive, HIV-positive child.
    Soler Palacin P; Torrent A; Rossich R; Moraga FA; Yeste D; Carreño JC; Encabo G; Figueras C
    J Pediatr Endocrinol Metab; 2007 Aug; 20(8):933-8. PubMed ID: 17937065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone disorders in human immunodeficiency virus infection.
    Glesby MJ
    Clin Infect Dis; 2003; 37 Suppl 2():S91-5. PubMed ID: 12942380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone health and human immunodeficiency virus infection.
    Schafer JJ; Manlangit K; Squires KE
    Pharmacotherapy; 2013 Jun; 33(6):665-82. PubMed ID: 23553497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection--a risk factor for osteoporosis.
    Thomas J; Doherty SM
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):281-91. PubMed ID: 12843738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV and its effects on bone: a primer for rheumatologists.
    Gedmintas L; Solomon DH
    Curr Opin Rheumatol; 2012 Sep; 24(5):567-75. PubMed ID: 22820515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and bone loss in HIV.
    Hileman CO; Overton ET; McComsey GA
    Curr Opin HIV AIDS; 2016 May; 11(3):277-84. PubMed ID: 26890209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteopathies that weaken HIV-infected patients].
    Rey D
    Presse Med; 2003 Dec; 32(39):1857-63. PubMed ID: 14713883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
    Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
    Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Are bones in HIV-infected patient really fragile?].
    Biver E; Ciaffi L; Rizzoli R; Calmy A
    Rev Med Suisse; 2013 Jun; 9(390):1246-50. PubMed ID: 23821841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valid treatment options for osteoporosis and osteopenia in HIV-infected persons.
    Clay PG; Voss LE; Williams C; Daume EC
    Ann Pharmacother; 2008 May; 42(5):670-9. PubMed ID: 18413693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral abnormalities in persons with HIV infection: signal or noise?
    Singh K; Moyle GJ
    AIDS Read; 2006 Aug; 16(8):407-10, 413-8. PubMed ID: 16933375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.